224 related articles for article (PubMed ID: 30863861)
1. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
[TBL] [Abstract][Full Text] [Related]
3. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of prognostic factors in patients with nodular melanoma.
Susok L; Stücker M; Bechara FG; Stockfleth E; Gambichler T
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2759-2764. PubMed ID: 33630139
[TBL] [Abstract][Full Text] [Related]
5. Five-year survival in patients with nodular and superficial spreading melanomas in the US population.
Allais BS; Beatson M; Wang H; Shahbazi S; Bijelic L; Jang S; Venna S
J Am Acad Dermatol; 2021 Apr; 84(4):1015-1022. PubMed ID: 33253834
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
7. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
8. Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.
Lattanzi M; Lee Y; Simpson D; Moran U; Darvishian F; Kim RH; Hernando E; Polsky D; Hanniford D; Shapiro R; Berman R; Pavlick AC; Wilson MA; Kirchhoff T; Weber JS; Zhong J; Osman I
J Natl Cancer Inst; 2019 Feb; 111(2):180-188. PubMed ID: 29912415
[TBL] [Abstract][Full Text] [Related]
9. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
10. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
11. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.
Flørenes VA; Emilsen E; Dong HP; Førsund M; Holm R; Slipicevic A
Cancer Med; 2015 Jun; 4(6):903-13. PubMed ID: 25663244
[TBL] [Abstract][Full Text] [Related]
12. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
14. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index.
Schmiegelow P; Schroiff R; Breitbart E; Bahnsen J; Lindner J; Jänner M
Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):47-59. PubMed ID: 3085340
[TBL] [Abstract][Full Text] [Related]
16. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
17. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
18. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
19. Subtyping Cutaneous Melanoma Matters.
El Sharouni MA; van Diest PJ; Witkamp AJ; Sigurdsson V; van Gils CH
JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa097. PubMed ID: 33409460
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of malignant melanoma according to subtype.
Lin MJ; Mar V; McLean C; Wolfe R; Kelly JW
Australas J Dermatol; 2014 Feb; 55(1):35-42. PubMed ID: 24283461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]